Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)

Price$0.33

Favorite Metrics

Price vs S&P 500 (26W)-73.85%

Price vs S&P 500 (4W)-7.67%

Market Capitalization$1.94M

All Metrics

Book Value / Share (Quarterly)$0.28

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-6.17%

Price vs S&P 500 (YTD)-20.41%

Gross Margin (TTM)-3.70%

Net Profit Margin (TTM)-4956.03%

EPS (TTM)$-0.15

10-Day Avg Trading Volume9.82M

EPS Excl Extra (TTM)$-0.15

EPS (Annual)$-0.07

Gross Margin (Annual)-6.27%

Cash / Share (Quarterly)$0.15

Revenue Growth QoQ (YoY)-43.87%

ROA (Last FY)-89.43%

EBITD / Share (TTM)$-0.14

Operating Margin (TTM)-5094.66%

Cash Flow / Share (Annual)$-0.05

P/B Ratio0.41x

P/B Ratio (Quarterly)20.81x

Net Income / Employee (Annual)$-0

Net Interest Coverage (TTM)-39.54x

EPS Incl Extra (Annual)$-0.07

Current Ratio (Annual)0.27x

Quick Ratio (Quarterly)1.48x

3-Month Avg Trading Volume1.31M

52-Week Price Return-93.24%

Revenue / Employee (TTM)$0

P/S Ratio (Annual)64.87x

Asset Turnover (Annual)0.03x

52-Week High$9.50

EPS Excl Extra (Annual)$-0.07

26-Week Price Return-65.10%

Quick Ratio (Annual)0.26x

13-Week Price Return-29.18%

Current Ratio (Quarterly)3.58x

Enterprise Value$-0.612

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-3122.10%

Cash / Share (Annual)$0.00

3-Month Return Std Dev162.77%

Net Income / Employee (TTM)$-0

Net Interest Coverage (Annual)-75.95x

EPS Basic Excl Extra (Annual)$-0.07

Total Debt / Equity (Quarterly)0.03x

EPS Incl Extra (TTM)$-0.15

Receivables Turnover (Annual)1.25x

P/S Ratio (TTM)43.94x

Revenue / Share (Annual)$0.00

Price vs S&P 500 (52W)-128.33%

Year-to-Date Return-16.27%

5-Day Price Return-4.56%

EPS Normalized (Annual)$-0.07

Net Profit Margin (Annual)-3229.59%

Month-to-Date Return14.45%

EBITD / Share (Annual)$-0.06

Operating Margin (Annual)-3404.93%

LT Debt / Equity (Quarterly)0.02x

EPS Basic Excl Extra (TTM)$-0.15

Pretax Margin (TTM)-4848.50%

Price vs S&P 500 (13W)-32.04%

Beta0.98x

Revenue / Share (TTM)$0.00

52-Week Low$0.28

About

Cuprina Holdings (Cayman) Ltd specializes in chronic wound management through its MEDIFLY product line, which uses sterile blowfly larvae as a biological debridement tool. MEDIFLY offers a clinically proven alternative to traditional surgical debridement for chronic wounds. The company also operates in the health and beauty sector.